phenylpropanolamine has been researched along with Adenoma, Prostatic in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (65.52) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, HC; Kuo, YC; Liao, CH | 1 |
| Kaplan, SA | 2 |
| He, JY; Shi, GW; Wang, YY; Zhang, YB | 1 |
| Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA | 1 |
| Bavendam, T; Carlsson, M; Chancellor, M; Guan, Z; Kaplan, SA; Roehrborn, CG | 1 |
| Andersson, KE | 1 |
| Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Kreder, K; Rovner, ES; Sussman, DO | 1 |
| Bavendam, T; Guan, Z; Kaplan, SA; Kraus, SR; Roehrborn, CG; Wang, JT | 1 |
| Endeshaw, Y; Johnson, TM; Nagamia, Z; Ouslander, JG; Vaughan, CP | 1 |
| Geng, H; Wu, ZL | 1 |
| Burkart, M; Höfner, K; Jacob, G; Jonas, U | 2 |
| Fukuhara, S; Hirai, T; Kiuchi, H; Kojimaan, Y; Miyagawa, Y; Nakayama, J; Okuyama, A; Takahashi, T; Takao, T; Tsujimura, A; Uchida, K; Ueda, T; Yamamoto, K | 1 |
| Abrams, P; Brodsky, M; Chapple, CR; Guan, Z; Herschorn, S; Wang, JT | 1 |
| Bo, JJ; Gu, WD; Leng, J; Liu, DM; Lü, JW; Sun, YM | 1 |
| Chang, HC; Chiu, B; Chung, SD; Kuo, HC; Liao, CH | 1 |
| Gan, W; Jia, HT; Li, YF; Luo, MH; Xie, S; Zhang, SF | 1 |
| Athanasopoulos, A; Barbalias, G; Fisfis, J; Giannitsas, K; Gyftopoulos, K; Perimenis, P | 1 |
| Chancellor, MB; Kim, HW; Koh, JS; Lee, JY; Lee, SJ; Suh, HJ | 1 |
| Athanasopoulos, A; Perimenis, P | 1 |
| Kaplan, SA; Te, AE; Walmsley, K | 1 |
| Burnett, AL; Wein, AJ | 1 |
| Alamanis, C; Giannopoulos, A; Mitropoulos, D; Papadoukakis, S; Zervas, A | 1 |
| Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Roehrborn, CG; Rovner, ES | 1 |
| Subramonian, K; Young, JG | 1 |
| Amarshi, N; Bell, WA | 1 |
| Li, HZ; Wang, W; Xiao, H; Yang, Y; Zhang, X; Zhang, Y; Zhao, XF | 1 |
| O'Leary, MP | 1 |
2 review(s) available for phenylpropanolamine and Adenoma, Prostatic
| Article | Year |
|---|---|
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases | 2005 |
Benign prostatic hyperplasia in primary care: what you need to know.
Topics: Age Distribution; Aged; Aged, 80 and over; Benzhydryl Compounds; Biopsy, Needle; Cresols; Humans; Immunohistochemistry; Incidence; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders | 2006 |
15 trial(s) available for phenylpropanolamine and Adenoma, Prostatic
| Article | Year |
|---|---|
Predictors of successful first-line antimuscarinic monotherapy in men with enlarged prostate and predominant storage symptoms.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Endosonography; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Retention | 2013 |
[Cardura monotherapy versus combination therapy of cardura and tolterodine L-tartrate tablets for II° ? benign prostatic hyperplasia with overactive bladder].
Topics: Aged; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenylpropanolamine; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2013 |
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Prostatism; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2008 |
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2008 |
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders | 2008 |
[Combination of tolterodine and tamsulosin for benign prostatic hyperplasia].
Topics: Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome | 2009 |
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostate-Specific Antigen; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2010 |
[Combination of tamsulosin and tolterodine alleviates refractory lower urinary tract symptoms in male patients].
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome | 2010 |
The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; International Cooperation; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention | 2011 |
[Tolterodine tartrate combined with alpha-receptor blocker for benign prostatic hyperplasia with detrusor overactivity].
Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2011 |
Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urodynamics | 2003 |
Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy.
Topics: Aged; Benzhydryl Compounds; Cresols; Humans; Male; Middle Aged; Phenylpropanolamine; Prostatectomy; Prostatic Hyperplasia; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence, Urge | 2006 |
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2006 |
Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prazosin; Prospective Studies; Prostatic Hyperplasia; Tolterodine Tartrate; Urination Disorders | 2007 |
Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Regression Analysis; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2007 |
12 other study(ies) available for phenylpropanolamine and Adenoma, Prostatic
| Article | Year |
|---|---|
Re: predictors of successful first-line antimuscarinic monotherapy in men with enlarged prostate and predominant storage symptoms.
Topics: Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life | 2014 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom | 2015 |
How many drugs for LUTS due to BPH are too many?
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride | 2008 |
A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.
Topics: Acetamides; Adrenergic alpha-Antagonists; Aged; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Epidemiologic Methods; Humans; Hypnotics and Sedatives; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Prazosin; Prostatic Hyperplasia; Pyrimidines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Probability; Prospective Studies; Prostatic Hyperplasia; Prostatism; Quality of Life; Regression Analysis; Severity of Illness Index; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics | 2010 |
[Clinical efficacy of tolterodine for patients with overactive bladder after insufficient efficacy by monotherapy with alpha1-adrenoceptor antagonist].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Re: Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
Topics: Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Prostatism; Quality of Life; Urinary Bladder, Overactive | 2011 |
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Humans; Male; Middle Aged; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics | 2004 |
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Incidence; Male; Middle Aged; Muscarinic Antagonists; Penile Erection; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Retention; Urination | 2005 |
Treatment of men with lower urinary tract symptoms and overactive bladder.
Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2007 |
Treatment of men with lower urinary tract symptoms and overactive bladder.
Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Interactions; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2007 |
Commentary on tolterodine for men with benign prostatic hyperplasia and lower urinary tract symptoms.
Topics: Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Tolterodine Tartrate; Treatment Outcome; Urination Disorders; Urodynamics | 2008 |